Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - COMMON STOCK
Common Stock APLS - Apellis Pharmaceuticals, Inc.
12 K
LAST VALUE
9.54%
2 YEAR CAGR
16.35%
5 YEAR CAGR
28.49%
10 YEAR CAGR